Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
P. Escalante (Rochester, MN, United States of America), T. Peikert (Rochester, MN, United States of America), V. Van Keulen (Rochester, MN, United States of America), C. Erskine (Rochester, MN, United States of America), A. Limper (Rochester, MN, United States of America). Immune reactive profiling in subjects at risk of latent tuberculosis infection with TST(+)/IGRA(-) results.. 5274

Member's Comments

No comment yet.

Related content which might interest you: Characterization of the HBHA response in TB patients with or without HIV infection. Source: International Congress 2017 – Human susceptibility to tuberculosis Year: 2017 The set of immunological tests for detection of active tuberculosis in children with latent infection Source: International Congress 2019 – Paediatric tuberculosis Year: 2019 Comparison of effector T-cell responses in patients with active TB disease compared to latent TB infection Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease Year: 2007 Interferon-γ release assays for the diagnosis of latent tuberculosis infection in HIV-seropositive individuals Source: Annual Congress 2008 - Interferon-gamma methods for the diagnosis of tuberculosis infection and disease Year: 2008 Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011 Combined phenotypical and functional analysis of M. tuberculosis specific immunity for diagnosing active infection and risk assessment in latently infected individuals Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection Year: 2014 A combinatorial dual-immunoassay predicts reactivation risk for patients with previously incomplete treatment for latent tuberculosis infection Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016 IFN-gamma response on T-cell based assays in HIV patients for detection of tuberculosis infection Source: Annual Congress 2008 - New methods to diagnose tuberculosis infection and disease Year: 2008 Identification of high risk factors for development of active tuberculosis in children with latent tuberculosis infections Source: International Congress 2017 – Clinical challenges in chronic lung diseases Year: 2017 Expression of the PDCD1 gene to determine active tuberculosis infection in children and adolescents with latent TB infection Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis Year: 2020 Direct costs of three models for the screening of latent tuberculosis infection Source: Eur Respir J 2006; 28: 45-50 Year: 2006 Different genetics background of patients with latent tuberculosis infection versus active tuberculosis Source: International Congress 2017 – Asthma genetics and genomics in patients and populations Year: 2017 Utility of mycobacterium tuberculosis Rv0081-specific host gene expression to distinguish latent infection from active tuberculosis disease Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016 Multiple cytokine response to mycobacterium tuberculosis with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 What is latent tuberculosis infection (LTBI)? Source: Annual Congress 2009 - Microbial colonisation or latency: a foot in the door to respiratory infections Year: 2009 Latent tuberculosis infection treatment in subjects with autoimmune diseases and T-cell interferon-γ responses Source: Annual Congress 2009 - Frontiers in the diagnosis of tuberculosis Year: 2009 Utility of Th1-cell immune responses in differentiating active tuberculosis from latent tuberculosis infection Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 Modulation of QuantiFERON-TB-Gold Plus response in patients with active tuberculosis and latent infection during treatment Source: International Congress 2017 – Migrants and screening Year: 2017 Our experience of T cell assays in the diagnosis of MTB disease and latent infection Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease Year: 2007 The prevalence of latent pulmonary tuberculosis infection (LTBI) in low and high risk populations in Ireland Source: Eur Respir J 2005; 26: Suppl. 49, 425s Year: 2005